Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of British Columbia

$772,999.00

Expanding the number of treatable intellectual disabilities through an integrated "-omics" approach

EF 2012-13

Résumé
Intellectual disability (ID) affects 2-3% of children and adults, or 140-210 million people worldwide. Defined strictly as low IQ, ID can have devastating lifelong effects on all aspects of life. The health cost of ID equals that of stroke, heart disease and cancer combined. The burden on families is incalculable. In most cases of ID, we do not know the cause (the majority is genetic), and so cannot provide effective treatment. ID can be an unchangeable fate for a child. Via our "Treatable Intellectual Disability Endeavour in British Columbia" (TIDE-BC) research, we found 81 published ID conditions that could be treated for underlying cause. These "inborn errors of metabolism" usually affect important enzymes and are treated using special diets, medications or stem cell transplants. In TIDE-BC, by careful screening, we identified treatable causes of ID in 5% of patients so far. In some cases, treatment has completely changed the child's life. Here, our team of doctors and scientists will use a comprehensive and individual approach to discovering more treatable genetic causes of ID. We have studied 8 families so far, and found one new treatable cause and five probable causes. Next ,we expand our approach in a total of 50 families, and the results will be directly implemented it into clinical practice via TIDE-BC. Ultimately, our aim is to be able to quickly diagnose the cause of ID in our patients, so we can provide correct treatments to each child to prevent brain damage and optimize health outcomes.
Programme
Operating Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
281094
Name
van Karnebeek Clara D
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
Expanding the number of treatable intellectual disabilities through an integrated "-omics" approach
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$772,999
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Discovery; Global Developmental Delay; Inborn Errors Of Metabolism; Intellectual Disability; Knowledge Translation; Metabolomics; Whole Exome Sequencing
Abstract
Intellectual disability (ID) affects 2-3% of children and adults, or 140-210 million people worldwide. Defined strictly as low IQ, ID can have devastating lifelong effects on all aspects of life. The health cost of ID equals that of stroke, heart disease and cancer combined. The burden on families is incalculable. In most cases of ID, we do not know the cause (the majority is genetic), and so cannot provide effective treatment. ID can be an unchangeable fate for a child. Via our "Treatable Intellectual Disability Endeavour in British Columbia" (TIDE-BC) research, we found 81 published ID conditions that could be treated for underlying cause. These "inborn errors of metabolism" usually affect important enzymes and are treated using special diets, medications or stem cell transplants. In TIDE-BC, by careful screening, we identified treatable causes of ID in 5% of patients so far. In some cases, treatment has completely changed the child's life. Here, our team of doctors and scientists will use a comprehensive and individual approach to discovering more treatable genetic causes of ID. We have studied 8 families so far, and found one new treatable cause and five probable causes. Next ,we expand our approach in a total of 50 families, and the results will be directly implemented it into clinical practice via TIDE-BC. Ultimately, our aim is to be able to quickly diagnose the cause of ID in our patients, so we can provide correct treatments to each child to prevent brain damage and optimize health outcomes.
Competitiondate
201303
Approvedterm2
5 yrs 0 mth
Pinamesdelim
van Karnebeek, Clara D; Stockler, Sylvia; Wasserman, Wyeth W
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $772,999~ $0~